Denali Therapeutics Inc. (NASDAQ: DNLI), today announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation for tividenofusp alfa (DNL310) for the treatment ...

Denali Therapeutics Inc.'s stock remains stable despite trial setback in ALS. BLA filing for MPS II treatment on track. Click ...

Denali obtains Breakthrough Therapy Designation for its experimental candidate, tividenofusp alfa (DNL310), for the treatment of pateints with Hunter syndrome.

Robert W. Baird assumed coverage on shares of Denali Therapeutics (NASDAQ:DNLI – Free Report) in a research note released on ...

President Volodymyr Zelenskyy has explained in detail in his response to the petition why members of the Verkhovna Rada are ...

On a recent visit to Washington DC, Ho sat down with GEN Editorial Director Kevin Davies, PhD, to discuss Denali’s progress ...

Denali Therapeutics (NASDAQ:DNLI – Free Report) had its price objective cut by HC Wainwright from $90.00 to $87.00 in a ...

An update from JCR Pharmaceuticals Co., Ltd. ( (JP:4552) ) is now available.

Public will not have to change lives ‘radically’ for climate goal, MPs promised - Lifestyle change, such as diet and travel, ...

Prime Minister-in-waiting Stuart Young will be entitled to collect a prime ministerial pension for the rest of his life if he ...

Despite winning 6 Lok Sabha seats in 2024, party faces organizational challenges and alliance uncertainties in India’s ...